Target intelligence / Profile preview

Gram-negative bacteria cell membrane

Molecular classification
Other
01

Overview

The Gram-negative bacteria cell membrane is a structural component of Gram-negative bacteria, consisting of a complex cell envelope with an outer membrane, a thin peptidoglycan layer, and an inner (cytoplasmic) membrane. The outer membrane contains lipopolysaccharides (LPS), which act as potent endotoxins and are critical for immune system interactions and virulence[1][4][5]. The cell membrane structure is a barrier to many antibiotics, detergents, and dyes, contributing to Gram-negative bacteria’s notable antibiotic resistance[2][4]. This envelope plays crucial roles in protecting the bacteria from environmental threats, facilitating nutrient transport (via porins and transporters), and anchoring factors involved in adhesion and virulence[1][4][5]. Note: The membrane itself is not a direct drug target but is essential in mediating drug interaction, resistance, and virulence factors. The term "Aerobic Gram-negative bacteria cell membrane" is not a canonical therapeutic target but rather a general structural feature of a broad class of bacteria. Individual membrane proteins (e.g., efflux pumps, porins, LPS) within this membrane are considered drug targets, but the collective membrane is not typically classified as a single target[4][5].

Other names
Gram-negative bacterial outer membraneGram-negative outer membraneGram-negative cell envelope
02

Mechanism of action

Inhibition of cell wall synthesis (by β-lactams targeting penicillin-binding proteins) Disruption of membrane integrity (by polymyxins)

03

Biological functions

Structural barrierProtection from environmental stressRegulation of transportImmune interaction
04

Disease associations

Infection
05

Safety considerations

Endotoxin release toxicity (due to LPS)High intrinsic drug resistanceRisk of septic shock from LPS
06

Interacting drugs

β-lactam antibiotics (e.g., penicillins, cephalosporins)

2 more in the full profile.

07

Biomarkers

Lipopolysaccharide (LPS)Outer membrane proteins (OMPs)

Beyond the preview

Go deeper on Gram-negative bacteria cell membrane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gram-negative bacteria cell membrane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call